MedPath

Efficacy of Focused Shock Waves Combined With Adjuvant Therapy With Tendon Supplement

Not Applicable
Completed
Conditions
Fasciitis, Plantar
Interventions
Device: Focused shock wave
Dietary Supplement: Tendisulfur Pro
Registration Number
NCT04664712
Lead Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Brief Summary

Physical treatment with focused shock waves is effective in the treatment of tendonitis. Food supplements could facilitate the healing of tendinopathies when combined with shock wave therapy.

Detailed Description

A single-blind, randomized prospective study (level of evidence IB) was designed. Patients with plantar fasciitis were recruited and randomized to group A and group B. Group A was treated with focused shock waves alone and group B with a combination of focused shock waves and tendon supplement. Pain remission (primary endpoint) and functional recovery (secondary endpoint) are monitored in both groups at three time points (Months 0, 3, and 6).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • plantar heel pain diagnosed clinically and instrumentally (ultrasound) as plantar fasciitis, that has not responded to conservative treatment for at least six months;
Exclusion Criteria
  • History of previous fractures or ankle and heel surgery;
  • Recurrence of previous local painful episodes;
  • Lesion of the plantar fascia on US examination;
  • Presence of pathologies that affect the function of the foot (lumbar radiculopathy, Achilles tendinitis, Morton's neuroma, etc.);
  • Chronic inflammatory conditions such as psoriasis, psoriatic arthritis, spondyloarthritis, ankylosing spondylitis, rheumatoid arthritis, chronic inflammatory bowel disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
shock waveFocused shock wave-
shock wave and tendon supplementFocused shock wave-
shock wave and tendon supplementTendisulfur Pro-
Primary Outcome Measures
NameTimeMethod
Change in Visual Analogue Score (VAS)T1 (three months); T2 (six months)

The pain was quantified using the VAS scale with the scores ranging between 0 (no pain)

Secondary Outcome Measures
NameTimeMethod
Change in American Foot & Ankle Score (AOFAS)T0 (recruitment); T2 (six months)

The scores ranging between 100 (no disability) and 0 (maximum disability)

Roles & Maudsley (R&M)T2 (six months)

Monitorization of the patient's perception of improvement, with the scores ranging from 1 (excellent) to 4 (minimum).

Change in Foot Function Index (FFI)T0 (recruitment); T2 (six months)

The scores ranging between 100 (no disability) and 0 (maximum disability).

Trial Locations

Locations (1)

AOUC Policlinico di Bari - UOC Ortopedia e Traumatologia

🇮🇹

Bari, Italy

© Copyright 2025. All Rights Reserved by MedPath